MICHAEL DONOVAN: Open Payments
NPI 1669852448 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,924 in 214 payments from 29 companies in 2025. Trend: 2023 $3,688 · 2024 $42,856 · 2025 $26,924
Speaker / faculty: $15,600Food & beverage: $5,048Travel & lodging: $4,526Consulting: $1,750
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 76 | $22,235 |
| Gilead Sciences, Inc. | 33 | $2,690 |
| PFIZER INC. | 17 | $226 |
| ABBVIE INC. | 9 | $207 |
| Napo Pharmaceuticals Inc | 9 | $183 |
| Novo Nordisk Inc | 10 | $173 |
| Merck Sharp & Dohme LLC | 6 | $156 |
| Lilly USA, LLC | 9 | $137 |
| Theratechnologies Inc. | 5 | $130 |
| Abbott Laboratories | 5 | $116 |
Products named: APRETUDE, Yeztugo, DOVATO, Mytesi, CABENUVA, VRAYLAR, Biktarvy, NURTEC ODT.
Industry payments across MO — which companies pay providers there.
